Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Oncolytics Biotech Inc. has filed a Follow-on Equity Offerin

<< Previous

Bullboard Posts

Next >>

Comment by Angler101on Aug 04, 2024 9:46pm

81 Views

Post# 36164145

RE:RE:RE:RE:RE:RE:RE:Oncolytics Biotech Inc. has filed a Follow-on Equity Offerin

So, Notable......it was ok for you to post dogwhistle political dogma, but according to you, you're the only one allowed to?.....if that isn't the epotome of an elitist leftwing narcisist, I don't know what ever could be!

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec